Molecular Genetic Pathology in New York
10 providers, $97,743 in total reported payments from drug and device makers. Ranked below by lifetime general payments.
Ranking high here usually means a consulting or royalty arrangement, not wrongdoing. Payments to device inventors and trial investigators are legal, disclosed, and concentrated in a small number of people — which is exactly why a list like this has a steep top and a long flat tail.
What Medicare pays molecular genetic pathology clinicians in New York
Across 9 molecular genetic pathology clinicians in New York who billed Original Medicare Part B in 2024, Medicare allowed $508,877 in total — an average of $56,542 each, of which $56,542 was for services and the rest for drugs administered in the office.
This is not a salary. The rest is what Medicare allowed for services these clinicians billed — Original Medicare fee-for-service only. It excludes Medicare Advantage, which now covers more than half of Medicare enrollees, along with Medicaid and every commercial insurer, so for most clinicians it is a fraction of their practice. It is also gross revenue: staff, rent, supplies and malpractice premiums all come out of it before anyone is paid. Anyone quoting a figure like this as physician pay is misreading it.
Ranked by reported payments
- 1Mark EwaltNew York$38,399
- 2Doctor GoldsteinBronx$36,230
- 3James SolomonNew York$13,934
- 4Robert BurkBronx$4,730
- 5Sanjay MukhopadhyaySyracuse$2,000
- 6Tatyana GindinNew York$1,425
- 7Chad VanderbiltNew York$290
- 8Jamal BenhamidaNew York$283
- 9Shella MongiaRoslyn$271
- 10Christian EzidiegwuSyracuse$181